Analytical, Characterization and Stability Studies of Chemicals, Bulk Drugs and Drug Formulations

1997 ◽  
Author(s):  
Peter Lim
Keyword(s):  
Stability Studies ◽  
Drug Formulations ◽  
Analytical Characterization

Exploiting Kinetic Solubility Differences for Low Level Detection of Crystallinity in Amorphous Drug Formulations

2020 ◽  
Vol 16 (5) ◽  
pp. 529-538
Author(s):  
Gregory K. Webster ◽  
Cynthia A. Pommerening ◽  
Whitney W. Harman ◽  
Mathew A. Gragg ◽  
Jian-Hwa Han ◽  
...  
Keyword(s):  
Dosage Form ◽  
Amorphous State ◽  
Analytical Techniques ◽  
Drug Level ◽  
Drug Substance ◽  
Phase Iii ◽  
Drug Formulations ◽  
Total Recovery ◽  
Amorphous Drug ◽  
Kinetic Solubility

Background: Enabling formulations have been implemented by the pharmaceutical industry as an effective tool for keeping Active Pharmaceutical Ingredient (API) in an amorphous state. Upon dosing in the amorphous state, many drugs which fail to demonstrate bioactivity due to the limited solubility and bioavailability of their crystalline form become bioavailable. Purpose: The analytical techniques use today for crystallinity detection are challenged by the sensitivity and robustness needed to achieve a 5% quantitation limit in low dose drug products. Our laboratory has developed a novel procedure capable of meeting this sensitivity and selectivity requirement. This is achieved by exploiting the differences in kinetic solubility of the formulated amorphous and free crystalline forms of API currently being used in dosage form platforms. Methods: Representative amorphous drug formulations were prepared and spiked with varying levels of crystalline drug substances to evaluate the selectivity and recovery of the crystalline drug substance from the product formulation. Kinetic solubility testing using a (i) Particle wetting phase, (ii) Particle suspending/erosion phase, (iii) Sampling time point and (iv) A total recovery determination for the drug substance. Results: The method selectively and quantitatively distinguishes crystalline drug substance from amorphous drug substance for samples spiked from 2.5% to 10% of the nominal label concentration of the API in the dosage form matrix. Conclusion: The kinetic solubility approach reported here achieves sensitive crystallinity quantitation for low drug level amorphous drug formulations at levels not yet achieved by complimentary analytical techniques.

Experimental and Analytical Characterization of Firebrand Ignition of Home Insulation Materials

2019 ◽  
Vol 55 (3) ◽  
pp. 1027-1056 ◽  
Author(s):  
Savannah S. Wessies ◽  
Michael K. Chang ◽  
Kevin C. Marr ◽  
Ofodike A. Ezekoye
Keyword(s):  
Analytical Characterization ◽  
Insulation Materials

Plasma-activated water from DBD as a source of nitrogen for agriculture: Specific energy and stability studies

2021 ◽  
Vol 129 (9) ◽  
pp. 093303
Author(s):  
Ganesh Subramanian P. S. ◽  
Ananthanarasimhan J. ◽  
Leelesh P. ◽  
Harsha Rao ◽  
Anand M. Shivapuji ◽  
...  
Keyword(s):  
Specific Energy ◽  
Stability Studies ◽  
Plasma Activated Water

Preparation, characterization and stability studies of cross-linked α-amylase aggregates (CLAAs) for continuous liquefaction of starch

2021 ◽  
Vol 173 ◽  
pp. 267-276
Author(s):  
Hidayat Ullah ◽  
Sidra Pervez ◽  
Shehzad Ahmed ◽  
Kashif Syed Haleem ◽  
Sadia Qayyum ◽  
...  
Keyword(s):  
Stability Studies

Peculiarities of perovskite photovoltaics degradation and how to account for them in stability studies

2020 ◽  
Author(s):  
Mark V. Khenkin ◽  
Anoop K.M. ◽  
Iris Visoly-Fisher ◽  
Francesco Di Giacomo ◽  
Ilker Dogan ◽  
...  
Keyword(s):  
Stability Studies
Sign in / Sign up

Export Citation Format

Share Document